Description: In this webcast, we will speak with actuarial leaders who developed their personal brand over several years to better understand just how powerful having a personal brand can be in actuarial work.

Description: With the mandated health plan transparency files, health plans and providers are now able to substantially enhance their provider contracting efforts. Although the files are large and cumbersome they are market disruptors and provide new insights for provider contracting efforts. Explore a demonstration on the type of information now available and how it can be used to enhance this from both a health plan and health care provider perspective.

Description: As companies have reported their latest financials for 2023, LDTI is in its full swing for the public companies. Under US GAAP reinsurance accounting methods can be daunting. Add onto this legacy practices related to reinsurance reporting and this may lead to significant unwinding and implementation efforts. This session will discuss industry practices commonly applied to US GAAP reinsurance reported balances such that LDTI adopters can gather deeper insights into the LDTI impact. Specifically, the session will explain the two most popular methods to value reinsurance under LDTI, methods applying a direct measurement of the reinsurance net cost and a method that recognizes ceded asset balances and a cost of reinsurance (“CoRe”). The session will present simplified direct and ceded models to demonstrate how the actuarial balances under LDTI impact GAAP book profits for different underlying products and reinsurance types.

Description: This three-part series provides an overview of the rapidly evolving and dynamic gene and cellular therapy landscape, from the clinical, historical, and risk transfer perspectives. It covers the actuarial considerations in pricing cell and gene insurance and reinsurance, the value assessment of the therapies, manufacturer pricing, and reinsurance cost.

Description: The Inflation Reduction Act represents the most significant changes to the Part D program since its inception 20 years ago. The implications will not only alter the benefits offered by Medicare Advantage (MAPD) and Prescription Drug Plans (PDP) but will alter the Part D cash flows and the seasonality of such amounts for interim reporting periods. In this session, we will provide a brief overview of the IRA changes and dive into how the changes could impact the 2008 Medicare Part D Accounting Practice Note.

Description: Explore a brief overview of federal income taxation of health insurers and selected technical tax topics during this panel discussion webcast. You'll dive into the evolution of heath insurers and healthcare-related services and the arising questions regarding their risk-bearing activities, as well as whether or not certain types of healthcare businesses qualify as "insurance companies" for federal income tax purposes. Also, expect to learn about loss reserves for guaranteed renewable contracts and how they can affect insurance company tax status. This webcast will continue to highlight how the IRS challenges loss reserves of health insurers as the panelists review the status of tax cases, IRS guidance and recent IRS activity regarding "margins."

Description: Dive into the released enhancements of MIM-2021, including a run through of its purpose and evolution, during this webcast. The Mortality and Longevity Strategic Research Program plans to release these updates in October. You will leave this webcast with an understanding of how to create a mortality improvement scale using the necessary steps and tools. Learn how to use MIM-2021 through instruction and demonstration that will properly prepare you to utilize this tool. There will be time for questions where you can ask about the projection process or provide feedback.

Description: "This session will explore the critical challenges and solutions surrounding algorithmic fairness in the life insurance industry. The presenters will delve into the fundamental mechanisms of model bias, examining how predictive algorithms can yield outcomes that systematically discriminate against certain groups through flawed machine learning processes, erroneous assumptions, or biased data. Participants will gain insights into the various manifestations of bias in insurance models and understand their profound implications for both consumers and insurers. Real-world case studies and examples from the insurance industry will illustrate these concepts, while a discussion of recent regulatory developments will provide context for compliance requirements. This session is essential for actuaries, data scientists, and insurance professionals committed to developing and maintaining ethical, unbiased predictive models."

Description: The Individual Life Experience Committee continues to unlock valuable insights from the VM51 data as the National Association of Insurance Commissioners (NAIC) releases it. In this session, attendees will get a preview of individual life mortality patterns during COVID-19 for more than 100 companies in the NAIC data from 2020 to 2021, the first years of the pandemic. Attendees will also see early findings from the Committee's latest initiatives. These include integrating predictive analytics into its reporting products, assessing the impact of simplified and accelerated underwriting, exploring joint life mortality, evaluating company differences, and continuing its research into old-age patterns. Attendees will leave the session armed with additional knowledge for assessing best-estimate mortality for valuation.

Description: This session guides actuaries through the key steps of building a principles-based valuation model for a life product, starting with a brief overview of key requirements in LDTI and VM-20.